Literature DB >> 17227476

Heritability for plasma VEGF concentration in the Stanislas family study.

Hind Berrahmoune1, Bernard Herbeth, John V Lamont, Christine Masson, Peter S Fitzgerald, Sophie Visvikis-Siest.   

Abstract

Vascular endothelial growth factor (VEGF), a key regulator of blood vessel function during angiogenesis, has been related to various diseases including atherosclerosis, neurodegenerative disorders and cancers. However, data about genetic determinants of its concentration in blood are scarce. The present study aimed at estimating additive genetic heritability, household component effect and the influence of 3 common VEGF polymorphisms on plasma VEGF concentration. A random sub-sample of 160 nuclear families (647 individuals), aging from 5 to 57, was obtained from the Stanislas Family Study. Plasma VEGF concentration was measured by a multiplexing ELISA and genotyping of the polymorphisms C(-460)T, G(405)C and C(936)T of the VEGF gene was carried out by RFLP. After adjustment for the influence of known environmental covariates, significant familial correlations were observed for plasma VEGF concentration (P< or = 0.01 and P< or = 0.001) for all the various pairs of relatives, except between spouses. In addition, variance component analysis showed no significant household common environment contribution to variability of this trait, while the genetic contribution accounted for 60.6% regardless of the 4 classes of relatives. Taking the three polymorphisms into account did not modify the variance components. These results show that plasma VEGF concentrations are under genetic control in healthy families and that none of the 3 candidate polymorphisms significantly altered heritability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227476     DOI: 10.1111/j.1469-1809.2006.00298.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  14 in total

1.  Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Authors:  Stephanie Debette; Sophie Visvikis-Siest; Ming-Huen Chen; Ndeye-Coumba Ndiaye; Ci Song; Anita Destefano; Radwan Safa; Mohsen Azimi Nezhad; Douglas Sawyer; Jean-Brice Marteau; Vanessa Xanthakis; Gerard Siest; Lisa Sullivan; Michele Pfister; Holly Smith; Seung-Hoan Choi; John Lamont; Lars Lind; Qiong Yang; Peter Fitzgerald; Erik Ingelsson; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

2.  Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome.

Authors:  Ewa Błaszczyk; Jakub Gawlik; Joanna Gieburowska; Agnieszka Tokarska; Małgorzata Kimsa-Furdzik; Grzegorz Hibner; Tomasz Francuz; Aneta Gawlik
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

3.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983

4.  Vascular endothelial growth factor (VEGF)-related single nucleotide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian patients with type 2 diabetes mellitus (T2DM).

Authors:  Rifet Terzić; Ines Cilenšek; Ruda Zorc Pleskovič; Sara Mankoč; Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 5.  Identifying Common Genetic Risk Factors of Diabetic Neuropathies.

Authors:  Ini-Isabée Witzel; Herbert F Jelinek; Kinda Khalaf; Sungmun Lee; Ahsan H Khandoker; Habiba Alsafar
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-28       Impact factor: 5.555

6.  Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.

Authors:  Seung Hoan Choi; Daniela Ruggiero; Rossella Sorice; Ci Song; Teresa Nutile; Albert Vernon Smith; Maria Pina Concas; Michela Traglia; Caterina Barbieri; Ndeye Coumba Ndiaye; Maria G Stathopoulou; Vasiliki Lagou; Giovanni Battista Maestrale; Cinzia Sala; Stephanie Debette; Peter Kovacs; Lars Lind; John Lamont; Peter Fitzgerald; Anke Tönjes; Vilmundur Gudnason; Daniela Toniolo; Mario Pirastu; Celine Bellenguez; Ramachandran S Vasan; Erik Ingelsson; Anne-Louise Leutenegger; Andrew D Johnson; Anita L DeStefano; Sophie Visvikis-Siest; Sudha Seshadri; Marina Ciullo
Journal:  PLoS Genet       Date:  2016-02-24       Impact factor: 5.917

7.  Genetic variation determines VEGF-A plasma levels in cancer patients.

Authors:  Federico Innocenti; Chen Jiang; Alexander B Sibley; Amy S Etheridge; Ace J Hatch; Stefanie Denning; Donna Niedzwiecki; Ivo D Shterev; Jiaxing Lin; Yoichi Furukawa; Michiaki Kubo; Hedy L Kindler; J Todd Auman; Alan P Venook; Herbert I Hurwitz; Howard L McLeod; Mark J Ratain; Raluca Gordan; Andrew B Nixon; Kouros Owzar
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

8.  VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans.

Authors:  Rita Schüler; Nicole Seebeck; Martin A Osterhoff; Veronica Witte; Agnes Flöel; Andreas Busjahn; Alexander Jais; Jens C Brüning; Turid Frahnow; Stefan Kabisch; Olga Pivovarova; Silke Hornemann; Michael Kruse; Andreas F H Pfeiffer
Journal:  Mol Metab       Date:  2018-02-12       Impact factor: 7.422

9.  What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?

Authors:  Amélie Bonnefond; Pierre-Jean Saulnier; Maria G Stathopoulou; Niels Grarup; Ndeye Coumba Ndiaye; Ronan Roussel; Mohsen Azimi Nezhad; Aurélie Dechaume; Olivier Lantieri; Serge Hercberg; Torsten Lauritzen; Beverley Balkau; Julia S El-Sayed Moustafa; Torben Hansen; Oluf Pedersen; Philippe Froguel; Guillaume Charpentier; Michel Marre; Samy Hadjadj; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 10.  Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis.

Authors:  Ian Buysschaert; Thomas Schmidt; Carmen Roncal; Peter Carmeliet; Diether Lambrechts
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.